Prevalence of Diabetic Kidney Disease and Evaluation of Drugs to Stop Disease Progression

Abstract

Background: Numerous factors, including genetic susceptibility, the duration and severity of diabetes, and lifestyle factors including smoking, obesity, and hypertension, affect the onset and progression of diabetic kidney disease. While strict glucose control and blood pressure management can halt the disease's course, current medicines are frequently insufficient to avert End Stage Renal Disease, and new therapeutics are required to enhance patient outcomes. 
Objective: The study is to find the prevalence of Diabetic Kidney Disease and evaluate drugs to stop the disease progression, determine the incidence and prevalence of the disease, evaluate the effectiveness of existing treatments, and develop new treatments to improve patient outcomes and prevent End-stage renal disease. 
Materials and Methods: This retrospective study aimed to determine the prevalence of Diabetic kidney disease and analyze the drugs used in its treatment among patients with diabetes who visited a tertiary care hospital for six months. Data was collected from electronic medical records, validated by two independent reviewers, and analyzed using Statistical Package for the Social Sciences. 
Conclusion: Diabetes represents a significant risk factor for Chronic Kidney Disease, with as many as one in three individuals with diabetes facing the possibility of developing Chronic kidney disease during their lifetime.